Wabel Emma A, Krieger-Burke Teresa, Watts Stephanie W
Department of Pharmacology and Toxicology, Michigan State University, East Lansing, Michigan, United States.
Am J Physiol Heart Circ Physiol. 2024 Dec 1;327(6):H1577-H1589. doi: 10.1152/ajpheart.00475.2024. Epub 2024 Oct 25.
The adipokine chemerin supports normal blood pressure and contributes to adiposity-associated hypertension, evidenced by falls in mean arterial pressure in Dahl SS rats given an antisense oligonucleotide against chemerin. In humans, circulating chemerin is positively associated with hypertension and aortic stiffness. Mechanisms of chemerin's influence on vascular health and disease remain unknown. We identified chemerin production in the vasculature-the blood vessel and its perivascular adipose tissue (PVAT). Here, using RNAScope, qPCR, isometric contractility, high-frequency ultrasound imaging, and Western blot in the Dahl SS rat, we test the hypothesis that endogenous chemerin amplifies agonist-induced vasoconstriction through the chemerin1 receptor and that chemerin drives aortic stiffness in the thoracic aorta. (chemerin1) expression was higher in the media, and (chemerin) expression was higher in the PVAT. Chemerin1 receptor antagonism via selective inhibitor CCX832 reduced maximal contraction to norepinephrine (NE) and serotonin (5-HT), but not angiotensin II, in isolated thoracic aorta (PVAT intact) from male Dahl SS rat. In females, CCX832 did not alter contraction to NE or 5-HT. Male, but not female, genetic chemerin knockout Dahl SS rats had lower aortic arch pulse wave velocity than wild types, indicating chemerin's role in aortic stiffness. Aortic PVAT from females expressed less chemerin protein than males, suggesting PVAT as the primary source of active chemerin. We show that chemerin made by the PVAT amplifies NE and 5-HT-induced contraction and potentially induces aortic stiffening in a sex-dependent manner, highlighting the potential for chemerin to be a key factor in blood pressure control and aortic stiffening. Chemerin1 receptor inhibition reduced norepinephrine (NE) and 5-HT-induced vasoconstriction in males. Genetic chemerin knockout (KO) resulted in lower pulse wave velocity in males. Differences in chemerin abundance in aorta perivascular adipose tissue (APVAT) may explain sex-dependent role of chemerin.
脂肪因子chemerin有助于维持正常血压,但也会导致肥胖相关的高血压,给Dahl SS大鼠注射抗chemerin的反义寡核苷酸后,其平均动脉压下降,证明了这一点。在人类中,循环中的chemerin与高血压和主动脉僵硬度呈正相关。chemerin影响血管健康和疾病的机制尚不清楚。我们发现血管系统(血管及其血管周围脂肪组织(PVAT))中存在chemerin的产生。在此,我们使用RNAScope、qPCR、等长收缩性、高频超声成像和蛋白质印迹法对Dahl SS大鼠进行研究,以检验内源性chemerin通过chemerin1受体放大激动剂诱导的血管收缩以及chemerin导致胸主动脉僵硬度增加这一假设。(chemerin1)在中膜中的表达较高,(chemerin)在PVAT中的表达较高。通过选择性抑制剂CCX832拮抗chemerin1受体,可降低雄性Dahl SS大鼠离体胸主动脉(PVAT完整)对去甲肾上腺素(NE)和5-羟色胺(5-HT)的最大收缩反应,但对血管紧张素II无影响。在雌性大鼠中,CCX832不会改变对NE或5-HT的收缩反应。雄性而非雌性基因敲除chemerin的Dahl SS大鼠的主动脉弓脉搏波速度低于野生型,表明chemerin在主动脉僵硬度中起作用。雌性大鼠的主动脉PVAT中chemerin蛋白表达低于雄性,提示PVAT是活性chemerin的主要来源。我们发现,PVAT产生的chemerin以性别依赖的方式放大NE和5-HT诱导的收缩,并可能导致主动脉僵硬度增加,这突出了chemerin可能是血压控制和主动脉僵硬度的关键因素。chemerin1受体抑制可降低雄性大鼠中去甲肾上腺素(NE)和5-HT诱导的血管收缩。基因敲除chemerin(KO)导致雄性大鼠脉搏波速度降低。主动脉血管周围脂肪组织(APVAT)中chemerin丰度的差异可能解释了chemerin的性别依赖性作用。